Full Press Release Details
BOTHELL, Wash., May 14, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the company will be participating in the following investor conferences:
22nd Annual Craig-Hallum Institutional Investor Conference
Minneapolis, MN at the Renaissance Hotel
Benchmark 2025 Healthcare House Call Virtual Conference
Jefferies Global Life Sciences Conference
New York, NY at the Marriott Marquis
Wolfe Research Small & Mid-Cap Conference
New York, NY at Wolfe Headquarters
Northland Growth Conference 2025
About BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.
Media & Investor Relations
Chief Financial Officer
Alliance Advisors IR
SOURCE BioLife Solutions, Inc.
21 %
more press release views with